In addition, recent investigations have shown that dex-stimulated gene expression is a sensitive marker of GR-resistance in MDD [13] and that common genetic variants that modulate the initial transcriptional response to GR activation increase the risk for depression [25]. This evidence concerns the gene NR3C1 and depressive symptom measurement.